Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 11, Number 11—November 2005

Research

Neutralizing Antibody Response and SARS Severity

Mei-Shang Ho*, Wei-Ju Chen*, Hour-Young Chen†, Szu-Fong Lin†, Min-Chin Wang†, Jiali Di†, Yen-Ta Lu‡, Ching-Lung Liu‡, Shan-Chwen Chang§, Chung-Liang Chao¶, Chwan-Chuen King§, Jeng-Min Chiou*, Ih-Jen Su#, and Jyh-Yuan Yang†Comments to Author 
Author affiliations: *Academia Sinica, Taipei, Taiwan; †Center for Disease Control, Taipei, Taiwan; ‡Taipei Mackay Memorial Hospital, Taipei, Taiwan; §National Taiwan University, Taipei, Taiwan; ¶Taipei Hospital, Taipei, Taiwan; #National Health Research Institutes, Taipei, Taiwan

Main Article

Table 1

Requirement of oxygen supplement in relation to the duration of illness among SARS-CoV–infected patients*†

Outcome Oxygen supplement
None or <2 L, % (n) >2 L by mask, % (n) By assisted ventilation, % (n)
Duration of illness (d)
<14 100.0 (5) 0 0
15–21 100.0 (16) 0 0
22–28 86.9 (20) 13.0 (3) 0
>28 23.5 (4) 23.5 (4) 52.9 (9)
Death 0 0 100 (11)

*N = 81; SARS-CoV, severe acute respiratory syndrome–associated coronavirus.
†p value for trend <0.0001.

Main Article

TOP